
Zafirlukast is an orally administered leukotriene receptor antagonist (LTRA) used for the chronic treatment of asthma. While zafirlukast is generally well tolerated, headaches and stomach upset often occur. Some rare side effects can occur, which can be life-threatening, such as liver failure. Eosinophilic granulomatosis with polyangiitis has been associated with zafirlukast, but the relationship is not thought to be causative. Overdoses of zafirlukast tend to be self-limiting.
via PubMed
{{Drugbox | Watchedfields = changed | verifiedrevid = 470635429 | IUPAC_name = Cyclopentyl 3-{2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl}-1-methyl-1H-indol-5-ylcarbamate | image = Zafirlukast.svg | image_class = skin-invert-image | width = 275 | image2 = Zafirlukast 3D ball-and-stick.png | image_class2 = bg-transparent
| tradename = Accolate | Drugs.com = | MedlinePlus = a697007 | DailyMedID = Zafirlukast | pregnancy_AU = B1 | pregnancy_US = B |pregnancy_US_comment= | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = POM | legal_US = | legal_status = | routes_of_administration = Oral
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).